Rain Oncology Inc. (NASDAQ:RAIN – Get Free Report) saw a large decline in short interest during the month of August. As of August 31st, there was short interest totalling 861,800 shares, a decline of 20.2% from the August 15th total of 1,080,000 shares. Approximately 4.3% of the shares of the stock are sold short. Based […]